In This Section      

Search Results

AREN03B2 Renal Tumors Classification, Biology, and Banking Study
Protocol Number:
Alan Friedman
Johns Hopkins Kimmel Cancer Center in Baltimore
To study kidney tumors so that we may learn more about them and find out more about how to treat subjects who have these tumors. We hope that as more information is learned, we can continue to improve treatments.
Age less than 30 years Patients with the following -Nephroblastic Tumor -Mesoblastic Tumor -Clear cell sarcoma -Rhabdoid Tumor -Renal Epitheliod Tumor -Angiolipoma -Ossifying Renal Tumor of infancy
We would like to have some of the tumor from your biopsy and/or surgery for this study. If your tumor returns after treatment, we would like to have some of that tumor tissue also. In addition, the AREN03B2 study surgeons would like to evaluate the information in the surgical reports from your hospital. â?¢ Blood will be taken for testing during your routine care. We would like to have about three extra teaspoonfuls of blood drawn when blood is drawn for routine tests. If you require further therapy, we would also like to have about two extra teaspoonfuls of blood when blood is taken at the end of all your therapy for your routine care, and a year after that, when blood is taken for your routine follow-up care. â?¢ Urine will be collected for testing during your routine care. We would like to have some of the urine collected (about two teaspoonfuls) for research tests. You will have studies done to find out the size of your tumor and its exact location in your body (CT, MRI, Ultrasound) during your routine care. We would like to have copies of these studies and reports sent to a central review center where the information will be used to make sure you are given the best treatment for your disease. Then study doctors will also use the information to decide which kind of imaging studies give the best information about the tumor.
Last Update
03/05/2019 05:03 AM